Patents by Inventor Sebastian Brenner

Sebastian Brenner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190381169
    Abstract: The present invention relates generally to a method for regulating immune reactions and test substances useful for same. Specifically, the method of the present invention relates to the modulation of the nerve growth factor receptor p75NTR, which is expressed by plasmacytoid dendritic cells. More specifically, the invention relates to a combination comprising at least one modulator of p75NTR signalling selected from a p75NTR antagonist or p75NTR agonist and at least one TLR receptor agonist selected from an agonist of TLR7 and/or TLR9. The invention further relates to the use of a combination of antagonists and agonists of p75NTR signalling and agonists of TLR7 and/or TLR9 as vaccine adjuvants and the invention provides vaccine compositions comprising antagonists and agonists of p75NTR signalling and agonists of TLR7 and/or TLR9.
    Type: Application
    Filed: April 24, 2019
    Publication date: December 19, 2019
    Inventors: Sebastian Brenner, Martin Ryser, Cornelia Richter, Sebastian Thieme
  • Publication number: 20170189522
    Abstract: The present invention relates generally to a method for regulating immune reactions and test substances useful for same. Specifically, the method of the present invention relates to the modulation of the nerve growth factor receptor p75NTR, which is expressed by plasmacytoid dendritic cells. More specifically, the invention relates to a combination comprising at least one modulator of p75NTR signalling selected from a p75NTR antagonist or p75NTR agonist and at least one TLR receptor agonist selected from an agonist of TLR7 and/or TLR9. The invention further relates to the use of a combination of antagonists and agonists of p75NTR signalling and agonists of TLR7 and/or TLR9 as vaccine adjuvants and the invention provides vaccine compositions comprising antagonists and agonists of p75NTR signalling and agonists of TLR7 and/or TLR9.
    Type: Application
    Filed: May 28, 2015
    Publication date: July 6, 2017
    Inventors: Sebastian BRENNER, Martin RYSER, Cornelia RICHTER, Sebastian THIEME
  • Patent number: 6481113
    Abstract: An accurate, portable skate blade gauge comprises an extruded body having a blade-receiving recess, a clamping screw for pressing the blade against a side wall of the recess, and a pivoted indicator arm having a base near the pivot for engagement with the blade edge, and a pointer remote from the pivot for indicating squareness of the blade. The pivot is a resilient pin of spring metal disposed in a hole in the gauge body and fixed to the bottom of the hole. A clearance between the pin and the wall of the hole allows the pin to flex when the skate blade is pressed against the base of the indicator. The resilience of the pin ensures that the blade remains in firm contact with the base of the indicator arm to achieve precise and accurate measurements.
    Type: Grant
    Filed: July 24, 2001
    Date of Patent: November 19, 2002
    Assignee: EdgeInspector, Inc.
    Inventors: Sebastian Brenner, Michael J. Iorio